awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43047178-D46ED2F6-B158-428D-8E74-8387033DB950
Q43047178-D46ED2F6-B158-428D-8E74-8387033DB950
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43047178-D46ED2F6-B158-428D-8E74-8387033DB950
Eicosapentaenoic acid could permit maintenance of the original ribavirin dose in chronic hepatitis C virus patients during the first 12 weeks of combination therapy with pegylated interferon-alpha and ribavirin. A prospective randomized controlled t
P2860
Q43047178-D46ED2F6-B158-428D-8E74-8387033DB950
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43047178-D46ED2F6-B158-428D-8E74-8387033DB950
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
adb1d7776c0d7899a8a48e2c817d7c5ff407355d
P2860
Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients.